HCW Biologics Inc. (HCWB)
1.68
-0.01
(-0.59%)
USD |
NASDAQ |
Oct 02, 16:00
1.65
-0.03
(-1.79%)
After-Hours: 06:56
HCW Biologics EPS Diluted (Quarterly) : -11.58 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -11.58 |
| March 31, 2026 | 1.389 |
| December 31, 2025 | -6.145 |
| September 30, 2025 | -12.09 |
| June 30, 2025 | -40.72 |
| March 31, 2025 | -11.80 |
| December 31, 2024 | -19.14 |
| September 30, 2024 | -0.1032 |
| June 30, 2024 | -0.404 |
| March 31, 2024 | -0.2006 |
| December 31, 2023 | -0.2967 |
| September 30, 2023 | -0.1375 |
| June 30, 2023 | -0.1199 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.1413 |
| December 31, 2022 | -0.1511 |
| September 30, 2022 | -0.1092 |
| June 30, 2022 | -0.098 |
| March 31, 2022 | -0.0575 |
| December 31, 2021 | -0.0887 |
| September 30, 2021 | -0.1146 |
| June 30, 2021 | -0.0881 |
| March 31, 2021 | -0.0905 |
| September 30, 2020 | -0.0815 |
| June 30, 2020 | -0.0833 |
| March 31, 2020 | -0.0724 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0762 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -15.37M |
| Revenue (Quarterly) | 0.1356M |
| Total Expenses (Quarterly) | 15.51M |
| Enterprise Value | 8.538M |
| Gross Profit Margin (Quarterly) | -163.0% |
| Profit Margin (Quarterly) | -11.34K% |
| Earnings Yield | -1.69K% |
| Normalized Earnings Yield | -1837.11 |